文献速递乳腺MR

3T 质子磁共振波谱在可疑乳腺肿块病变中的临床应用

1H-MR spectroscopy of suspicious breast mass lesions at 3T: a clinical experience.
PubMed 文献 · Radiol Med · 2016-12-15

前瞻性纳入乳腺X线/超声BI-RADS 4-5类肿块病变行3T单 voxel 1H-MRS,以tCho峰SNR≥2为恶性阈值;排除距皮肤或胸肌≤1 cm的病变后,敏感度89%(95%CI 80-95%)、特异度89%(95%CI 72-98%),但作者认为仍不足以避免穿刺活检。

要点

  • 3T 1H-MRS以tCho峰SNR≥2为恶性阈值,排除近皮肤/胸肌病变后敏感度和特异度均为89%。
  • MRS附加检查时间约8分钟,作者结论认为其诊断效能仍不足以替代穿刺活检。

核心结论

  • 排除距皮肤或胸肌≤1 cm的病变后,3T 1H-MRS对≥1 cm乳腺肿块病变诊断效能较高,但作者认为仍不足以避免穿刺活检。

研究设计与样本

  • 前瞻性研究,纳入乳腺X线/超声BI-RADS 4-5类病变患者,行增强乳腺MRI后单voxel PRESS序列MRS(TR/TE=3000/135 ms,VOI 1 cm³),以水峰FWHM≤45 Hz为可靠波谱标准,全部病变行穿刺取样,良性病变以最终病理或至少1年阴性随访为参考标准。

诊断标准与关键数值

  • 以3.21 ppm处总胆碱(tCho)峰SNR≥2为恶性阈值;可靠波谱115/127个病变(91%),平均FWHM 32.4 Hz(范围8-45 Hz);排除距皮肤≤1 cm(n=3)或距胸肌≤1 cm(n=11)的病变后,敏感度65/73(89%,95%CI 80-95%),特异度25/28(89%,95%CI 72-98%);仅计浸润性癌时敏感度61/68(90%,95%CI 81-96%)。

临床应用与阅片要点

  • 作者结论认为3T 1H-MRS对≥1 cm乳腺肿块病变诊断效能较高,但仍不足以避免穿刺活检。

局限性

  • 原文结论指出3T 1H-MRS诊断效能仍不足以避免穿刺活检。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To test 3T proton magnetic resonance spectroscopy (1H-MRS) for breast mass lesions.

METHODS: Patients with BI-RADS 4-5 lesions at mammography/ultrasound were prospectively enrolled. After contrast-enhanced breast MRI, single-voxel MRS (point-resolved volume selection, PRESS); pencil-beam shimming; volume of interest 1 cm3; TR/TE = 3000/135 ms) was performed. Spectra were considered reliable if the full width at half maximum (FWHM) of the water peak was ≤45 Hz. A signal-to-noise ratio of the total choline (tCho) peak at 3.21 ppm ≥2 was used as cutoff for malignancy. All lesions underwent needle sampling. Final pathology was available for all malignant lesions; for benign lesions the reference standard was final pathology or at least 1-year negative follow-up.

RESULTS: Reliable spectra were obtained in 115/127 lesions (91%), with a mean FWHM of 32.4 Hz (range 8-45 Hz). A tCho peak SNR ≥2 was detected in 66 malignant lesions (62 invasive cancers; 4 ductal carcinoma in situ) and in 3 benign lesions. Excluding lesions located ≤1 cm from the skin (n = 3) or pectoral muscle (n = 11), sensitivity was 65/73 [89%, 95% confidence interval (CI): 80-95%], and specificity 25/28 (89%) (95% CI: 72-98%). Considering only invasive cancers, sensitivity reached 61/68 (90%, 95% CI: 81-96%). MRS additional time was 8 min.

CONCLUSIONS: When lesions close to the skin or pectoral muscle are excluded, 3T 1H-MRS of mass lesions ≥1 cm showed a high diagnostic performance, however, insufficient to avoid needle biopsy.

来源:Radiol Med,查看原文。版权归原作者所有。

引用

  1. Montemezzi S, Cavedon C, Camera L, et al. 1H-MR spectroscopy of suspicious breast mass lesions at 3T: a clinical experience. Radiol Med. 2016. PMID: 27981485. doi:10.1007/s11547-016-0713-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。